Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose

Ann Allergy Asthma Immunol. 2022 Sep;129(3):373-374. doi: 10.1016/j.anai.2022.05.004. Epub 2022 May 17.
No abstract available

MeSH terms

  • Antibody Formation
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Hypersensitivity*
  • RNA, Messenger
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • mRNA Vaccines